Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:131-135
Published online before print October 25, 2007, doi: 10.1161/CIRCRESAHA.107.164699
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
102/1/131    most recent
CIRCRESAHA.107.164699v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boengler, K.
Right arrow Articles by Schulz, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boengler, K.
Right arrow Articles by Schulz, R.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Ischemic biology - basic studies
(Circulation Research. 2008;102:131.)
© 2008 American Heart Association, Inc.


Integrative Physiology

Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice

Kerstin Boengler, Astrid Buechert, Yvonne Heinen, Christin Roeskes, Denise Hilfiker-Kleiner, Gerd Heusch, Rainer Schulz

From the Institut für Pathophysiologie (K.B., A.B., Y.H., C.R., G.H., R.S.), Universitätsklinikum Essen; and Molekulare Kardiologie (D.H.-K.), Medizinische Hochschule Hannover, Germany.

Correspondence to Prof Dr Rainer Schulz, Institut für Pathophysiologie, Zentrum für Innere Medizin, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen, Germany. E-mail Rainer.schulz{at}uk-essen.de

The cardioprotection by ischemic preconditioning is lost in aged wild-type and in STAT3 (signal transducer and activator of transcription 3)-deficient mice. The aim of the present study was to analyze whether or not ischemic postconditioning (iPoco) was effective in aged mice hearts and whether iPoco was dependent on STAT3. Young (3 months) and aged (>13 months) C57Bl6/J mice underwent 30 minutes of ischemia and 2 hours of reperfusion without or with iPoco (3 cycles of 10 seconds of ischemia/10 seconds of reperfusion [3x10] or 5 cycles of 5 seconds of ischemia/5 seconds of reperfusion [5x5] at the beginning of reperfusion). In young mice, both iPoco3x10 and iPoco5x5 reduced infarct size (IS), whereas in aged mice, only iPoco5x5 was effective in reducing IS. In young mice, iPoco3x10 increased the phosphorylated over total STAT3 (phosphorylated STAT3/STAT3) ratio at 10 minutes of reperfusion in the postconditioned anterior wall compared with the control posterior wall. In aged mice hearts, total STAT3 and phosphorylated STAT3/STAT3 in the anterior wall at reperfusion were reduced compared with young mice hearts. In young mice hearts subjected to iPoco3x10 but pretreated with the JAK-2 inhibitor AG-490, phosphorylated STAT3/STAT3 was reduced in the anterior wall compared with untreated young mice hearts, and IS reduction by iPoco3x10 was abolished. Furthermore, in young mice with a cardiomyocyte-restricted deletion of STAT3, iPoco3x10 failed to reduce IS, whereas iPoco5x5 reduced IS. Thus, cardioprotection by iPoco is dependent on the postconditioning protocol in aged and STAT3-deficient hearts. The reduced levels of STAT3 with increasing age may contribute to the age-related loss of iPoco.


Key Words: signal transducer and activator of transcription 3 • ischemic postconditioning • aging




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Heusch
No RISK, no ... cardioprotection? A critical perspective
Cardiovasc Res, November 1, 2009; 84(2): 173 - 175.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Musiolik, P. van Caster, A. Skyschally, K. Boengler, P. Gres, R. Schulz, and G. Heusch
Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs
Cardiovasc Res, August 25, 2009; (2009) cvp271v2.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Boengler, R. Schulz, and G. Heusch
Loss of cardioprotection with ageing
Cardiovasc Res, July 15, 2009; 83(2): 247 - 261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Cardioprotective growth factors
Cardiovasc Res, July 15, 2009; 83(2): 179 - 194.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Granfeldt, D. J. Lefer, and J. Vinten-Johansen
Protective ischaemia in patients: preconditioning and postconditioning
Cardiovasc Res, July 15, 2009; 83(2): 234 - 246.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
K. A. Kaminski, A. Kozieradzka, T. Bonda, M. Banach, M. Kozuch, I. Wojtkowska, S. Dobrzycki, P. Kralisz, K. Nowak, P. Prokopczuk, et al.
Percutaneous Coronary Interventions Affect Concentrations of Interleukin 6 and Its Soluble Receptors in Coronary Sinus Blood in Patients With Stable Angina
Angiology, June 1, 2009; 60(3): 322 - 328.
[Abstract] [PDF]


Home page
Circ. Res.Home page
A. Skyschally, P. van Caster, K. Boengler, P. Gres, J. Musiolik, D. Schilawa, R. Schulz, and G. Heusch
Ischemic Postconditioning in Pigs: No Causal Role for RISK Activation
Circ. Res., January 2, 2009; 104(1): 15 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, K. Tamaki, and R. Bolli
Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2348 - H2355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. D. Goodman, S. E. Koch, G. A. Fuller-Bicer, and K. L. Butler
Regulating RISK: a role for JAK-STAT signaling in postconditioning?
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1649 - H1656.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. A. Frias, S. Somers, C. Gerber-Wicht, L. H. Opie, S. Lecour, and U. Lang
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Cardiovasc Res, October 1, 2008; 80(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Dow, A. Bhandari, and R. A. Kloner
Ischemic Postconditioning's Benefit on Reperfusion Ventricular Arrhythmias Is Maintained in the Senescent Heart
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 141 - 148.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. Przyklenk, M. Maynard, C. E. Darling, and P. Whittaker
Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1393 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. I. Jugdutt and A. Jelani
Aging and Defective Healing, Adverse Remodeling, and Blunted Post-Conditioning in the Reperfused Wounded Heart
J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1399 - 1403.
[Full Text] [PDF]